GET THE APP

..

Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Volume 11, Issue 8 (2022)

Research Article Pages: 1 - 4

Program against Cancer in Rwanda

El Hadji Seydou Mbaye*

DOI: 10.37421/2329-6771.2022.11.398

Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Organization (WHO), millions of lives could be saved each year if countries made use of existing knowledge and the best cost-effective methods to prevent and treat cancer. Therefore, the aim of this study is to estimate a provisional budget against cancer in low and middle incomes countries, according the GNI-PPP, the cancer incidence and the number of population. Economically country classification is determining with the Gross national income (GNI), per capita, Purchasing power parity (PPP), according the administrations of the International Monetary Fund (IMF), the World Bank (WB) and the Central Intelligence Agency (CIA). Cancer incidence data presented are based on the most recent data available at IARC. However, population compares estimates from the US Bureau of the Census. The provisional budget is establishing among the guidelines developed by WHO for regional and national cancer control programs according to national economic development. Provisional budget against cancer is estimated to 42,148.788 (thousands of U.S $) for a population of 11,901,484 persons in Rwanda.

Research Article Pages: 1 - 7

The Impact of Photobiomodulation for Oral Mucositis on the Quality of life of Head and Neck Cancer patients undergoing Radio Chemotherapy

Nathália M. Passos, Agda S. Costa, Juliana B. L. Dantas, Gabriela B. Martins, Hayana R. Lima, Alena R. A. P. Medrado and Manoela Carrera*

DOI: 10.37421/2329-6771.2022.11.397

Background: Photobiomodulation (PBM) has been used to prevent and manage Oral Mucositis (OM) due to its bio stimulating properties. We evaluated the impact of PBM for OM on the Quality of Life (QOL) of Head and Neck (HNC) patients undergoing radio-chemotherapy.

Methods: Patients were allocated randomly to the Laser (LO) and Control Group (LS). PBM was used three times a week. QoL assessment were undertaken at the 1st, 6th, 12th, 18th, and 24th radiotherapy sessions.

Results: The overall QOL scores decreased in both groups. A comparative analysis between the LO and LS groups demonstrated a worsening over time in the saliva, taste, swallowing, and recreation domains (p<0,05). The LS group demonstrated a greater impairment of QOL in chewing at the 1st (p= 0.011), 18th (p= 0.023) and 24th sessions (p= 0.012).

Conclusion: PBM prevented the manifestation of more severe OM degrees, improving the QOL at oral related domains.

arrow_upward arrow_upward